Quan-Xing Ni

1.7k total citations
25 papers, 1.3k citations indexed

About

Quan-Xing Ni is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Quan-Xing Ni has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Quan-Xing Ni's work include Pancreatic and Hepatic Oncology Research (18 papers), Neuroendocrine Tumor Research Advances (6 papers) and Pancreatitis Pathology and Treatment (6 papers). Quan-Xing Ni is often cited by papers focused on Pancreatic and Hepatic Oncology Research (18 papers), Neuroendocrine Tumor Research Advances (6 papers) and Pancreatitis Pathology and Treatment (6 papers). Quan-Xing Ni collaborates with scholars based in China, United States and Canada. Quan-Xing Ni's co-authors include Xianjun Yu, Jin Xu, Liang Liu, Jiang Long, Chun-Tao Wu, Hua-Xiang Xu, Wen-Quan Wang, Chen Liu, Chen Jin and He-Li Gao and has published in prestigious journals such as Journal of Nutrition, Cancer Letters and World Journal of Gastroenterology.

In The Last Decade

Quan-Xing Ni

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quan-Xing Ni China 18 638 462 282 223 211 25 1.3k
Sang‐Yeob Kim South Korea 24 440 0.7× 797 1.7× 262 0.9× 266 1.2× 164 0.8× 81 1.6k
Qiyun Tang China 23 282 0.4× 625 1.4× 366 1.3× 143 0.6× 179 0.8× 65 1.3k
Yao Yuan China 20 500 0.8× 855 1.9× 376 1.3× 170 0.8× 154 0.7× 72 1.6k
Wence Zhou China 18 574 0.9× 584 1.3× 452 1.6× 285 1.3× 398 1.9× 90 1.7k
Yun Zhu China 23 253 0.4× 522 1.1× 244 0.9× 409 1.8× 171 0.8× 63 1.3k
Suxia Han China 24 445 0.7× 1.0k 2.3× 518 1.8× 228 1.0× 131 0.6× 75 1.8k
Haiyan Yang China 23 498 0.8× 604 1.3× 347 1.2× 182 0.8× 157 0.7× 84 1.6k
Muxing Kang China 19 328 0.5× 579 1.3× 272 1.0× 154 0.7× 189 0.9× 33 1.1k
Ganfeng Xie China 22 297 0.5× 849 1.8× 576 2.0× 277 1.2× 121 0.6× 44 1.6k
Jun Ho Yi South Korea 22 552 0.9× 514 1.1× 324 1.1× 81 0.4× 163 0.8× 88 1.5k

Countries citing papers authored by Quan-Xing Ni

Since Specialization
Citations

This map shows the geographic impact of Quan-Xing Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan-Xing Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan-Xing Ni more than expected).

Fields of papers citing papers by Quan-Xing Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quan-Xing Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan-Xing Ni. The network helps show where Quan-Xing Ni may publish in the future.

Co-authorship network of co-authors of Quan-Xing Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Quan-Xing Ni. A scholar is included among the top collaborators of Quan-Xing Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quan-Xing Ni. Quan-Xing Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shuo, Hua-Xiang Xu, Hao Li, et al.. (2020). Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. World Journal of Gastroenterology. 26(8). 828–838. 117 indexed citations
2.
Li, Hao, Shi-Rong Zhang, Hua-Xiang Xu, et al.. (2019). SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer. Journal of Cancer. 10(12). 2670–2678. 24 indexed citations
3.
Gao, He-Li, Liang Liu, Zi-Hao Qi, et al.. (2018). The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis. Hepatobiliary & pancreatic diseases international. 17(2). 95–100. 50 indexed citations
4.
Li, Shuo, Hua-Xiang Xu, Chun-Tao Wu, et al.. (2018). Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis. 22(1). 15–36. 218 indexed citations
5.
Zhang, Shi-Rong, Hao Li, Wen-Quan Wang, et al.. (2018). Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma. European Journal of Surgical Oncology. 45(5). 769–775. 11 indexed citations
6.
Xu, Jin, et al.. (2018). Strategies for pancreatic anastomosis after pancreaticoduodenectomy: What really matters?. Hepatobiliary & pancreatic diseases international. 17(1). 22–26. 16 indexed citations
7.
Xu, Jin-Zhi, Wen-Quan Wang, Shi-Rong Zhang, et al.. (2018). Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer. Current Medicinal Chemistry. 26(40). 7196–7211. 10 indexed citations
8.
Xu, Jin-Zhi, Wen-Quan Wang, Shi-Rong Zhang, et al.. (2017). Intrinsic Contact Between T and N Classifications in Resected Well–Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms. Annals of Surgical Oncology. 25(3). 647–654. 6 indexed citations
9.
Xu, Hua-Xiang, Liang Liu, Wen-Quan Wang, et al.. (2016). Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma. Surgery. 161(2). 373–384. 43 indexed citations
10.
Liu, Liang, Hua-Xiang Xu, Wen-Quan Wang, et al.. (2016). Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. Oncotarget. 7(5). 5943–5956. 83 indexed citations
11.
Long, Jiang, Guopei Luo, Meng Guo, et al.. (2014). Cancer statistics: Current diagnosis and treatment of pancreatic cancer in Shanghai, China. Cancer Letters. 346(2). 273–277. 105 indexed citations
12.
Liu, Chen, Cheng He, Lu Yu, et al.. (2014). Epithelial–mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1855(1). 43–49. 38 indexed citations
13.
Luo, Guopei, Liang Liu, Chen Liu, et al.. (2014). Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma. Hepatobiliary & pancreatic diseases international. 13(6). 634–641. 22 indexed citations
14.
Zhang, Fei, Bin Liu, Zhen Wang, et al.. (2013). A Novel Regulatory Mechanism of Pim-3 Kinase Stability and Its Involvement in Pancreatic Cancer Progression. Molecular Cancer Research. 11(12). 1508–1520. 37 indexed citations
15.
Wang, Jing, Wei Zhang, Herbert Yu, et al.. (2013). Dietary Energy Density Is Positively Associated with Risk of Pancreatic Cancer in Urban Shanghai Chinese. Journal of Nutrition. 143(10). 1626–1629. 13 indexed citations
16.
Wu, Chun-Tao, Liang Liu, Jiang Long, et al.. (2013). Ligamentum teres hepatis patch enhances the healing of pancreatic fistula after distal pancreatectomy. Hepatobiliary & pancreatic diseases international. 12(6). 651–655. 13 indexed citations
17.
Wang, Jing, Wei Zhang, Herbert Yu, et al.. (2012). Green tea drinking and risk of pancreatic cancer: A large-scale, population-based case–control study in urban Shanghai. Cancer Epidemiology. 36(6). e354–e358. 36 indexed citations
18.
Liu, Chen, Bo Zhang, Feng Yang, et al.. (2010). Carbon nanotubes in cancer diagnosis and therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1806(1). 29–35. 245 indexed citations
19.
Li, Jinming, Wei Chen, Hao Wang, et al.. (2009). Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro. Acta Pharmacologica Sinica. 30(9). 1337–1343. 55 indexed citations
20.
Yang, Feng, Jiang Long, Chen Jin, et al.. (2008). Aberrant Hepatic Artery in Patients Undergoing Pancreaticoduodenectomy. Pancreatology. 8(1). 50–54. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang‐Yeob Kim Breakdown of academic impact, for papers by Qiyun Tang Breakdown of academic impact, for papers by Yao Yuan Breakdown of academic impact, for papers by Wence Zhou Breakdown of academic impact, for papers by Yun Zhu Breakdown of academic impact, for papers by Suxia Han Breakdown of academic impact, for papers by Haiyan Yang Breakdown of academic impact, for papers by Muxing Kang Breakdown of academic impact, for papers by Ganfeng Xie Breakdown of academic impact, for papers by Jun Ho Yi
Rankless by CCL
2026